SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
FDA Approves Janssen Therapeutics INTELENCE® (etravirine) Tablets for Treatment-Experienced Pediatric Patients With HIV-1, Following Priority Review